Editorial: Multimodality Treatment in Pancreatic Ductal Adenocarcinoma - Current Options and the Future Impact of Molecular Biological Profiling.
作者信息
Kornmann Marko, Kleger Alexander
机构信息
Klinik für Allgemein- und Viszeralchirurgie, Universitätsklinikum Ulm, Ulm, Germany.
Klinik für Innere Medizin I, Universitätsklinikum Ulm, Ulm, Germany.
出版信息
Visc Med. 2022 Feb;38(1):1-3. doi: 10.1159/000521419. Epub 2022 Jan 24.
Abstract
摘要
相似文献
1
Editorial: Multimodality Treatment in Pancreatic Ductal Adenocarcinoma - Current Options and the Future Impact of Molecular Biological Profiling.
Visc Med. 2022 Feb;38(1):1-3. doi: 10.1159/000521419. Epub 2022 Jan 24.
2
The past, present, and future status of multimodality treatment for resectable/borderline resectable pancreatic ductal adenocarcinoma.
Surg Today. 2020 Apr;50(4):335-343. doi: 10.1007/s00595-020-01963-2. Epub 2020 Jan 28.
3
Discussion: Current Multimodality Treatment Options in Pancreatic Cancer in Clinical Practice - What Is the Future Impact of Molecular Biological Profiling?
Visc Med. 2022 Feb;38(1):49-55. doi: 10.1159/000521847. Epub 2022 Jan 21.
4
Pharmacotherapeutic options for pancreatic ductal adenocarcinoma.
Expert Opin Pharmacother. 2022 Dec;23(18):2079-2089. doi: 10.1080/14656566.2022.2149322. Epub 2022 Nov 28.
5
Pancreatic ductal adenocarcinoma: the latest on diagnosis, molecular profiling, and systemic treatments.
Front Oncol. 2024 Jul 1;14:1386699. doi: 10.3389/fonc.2024.1386699. eCollection 2024.
6
Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future.
Lancet Oncol. 2020 Mar;21(3):e135-e145. doi: 10.1016/S1470-2045(19)30795-8.
7
Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma.
Mod Pathol. 2012 Jan;25(1):112-21. doi: 10.1038/modpathol.2011.142. Epub 2011 Oct 7.
8
Pancreatic Cancer: Current Multimodality Treatment Options and the Future Impact of Molecular Biological Profiling.
Visc Med. 2022 Feb;38(1):20-29. doi: 10.1159/000521631. Epub 2022 Jan 19.
9
Management of metastatic pancreatic cancer: Current treatment options and potential new therapeutic targets.
Crit Rev Oncol Hematol. 2015 Sep;95(3):318-36. doi: 10.1016/j.critrevonc.2015.03.008. Epub 2015 Apr 15.
10
Advanced pancreatic ductal adenocarcinoma - Complexities of treatment and emerging therapeutic options.
World J Gastroenterol. 2017 Apr 7;23(13):2276-2285. doi: 10.3748/wjg.v23.i13.2276.
本文引用的文献
1
Cell Type of Pancreatic Ductal Adenocarcinoma Origin: Implications for Prognosis and Clinical Outcomes.
Visc Med. 2022 Feb;38(1):4-10. doi: 10.1159/000520946. Epub 2021 Dec 27.
2
Pancreatic Cancer: Current Multimodality Treatment Options and the Future Impact of Molecular Biological Profiling.
Visc Med. 2022 Feb;38(1):20-29. doi: 10.1159/000521631. Epub 2022 Jan 19.
3
Resection of Recurrent Pancreatic Cancer: Who Can Benefit?
Visc Med. 2022 Feb;38(1):42-48. doi: 10.1159/000519754. Epub 2021 Nov 11.
4
Emerging Role of Exosomal-Derived Long Noncoding RNAs in Human PDAC.
Visc Med. 2022 Feb;38(1):30-36. doi: 10.1159/000520947. Epub 2021 Dec 20.
5
Molecular Profiling in Pancreatic Cancer: Current Role and Its Impact on Primary Surgery.
Visc Med. 2022 Feb;38(1):37-41. doi: 10.1159/000519755. Epub 2021 Oct 26.
6
Epigenetic Therapeutic Strategies to Target Molecular and Cellular Heterogeneity in Pancreatic Cancer.
Visc Med. 2022 Feb;38(1):11-19. doi: 10.1159/000519859. Epub 2021 Nov 19.
7
Curing pancreatic cancer.
Semin Cancer Biol. 2021 Nov;76:232-246. doi: 10.1016/j.semcancer.2021.05.030. Epub 2021 May 29.
8
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial.
Lancet Oncol. 2020 Apr;21(4):508-518. doi: 10.1016/S1470-2045(20)30074-7. Epub 2020 Mar 2.
9
The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
Lancet Gastroenterol Hepatol. 2019 Dec;4(12):934-947. doi: 10.1016/S2468-1253(19)30347-4. Epub 2019 Oct 21.
10
Cancer modeling meets human organoid technology.
Science. 2019 Jun 7;364(6444):952-955. doi: 10.1126/science.aaw6985.
Zotero 插件